Multiple extracellular antigens and immune mediators

Multiple extracellular antigens and immune mediators refers to a broad spectrum of circulating molecules involved in systemic inflammation and immune signaling rather than a single discrete molecular target. This category includes pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α), as well as chemokines, autoantibodies, and pathogen-associated molecular patterns (PAMPs) like bacterial endotoxins (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324730/). These mediators are central to the pathogenesis of the cytokine storm, sepsis, and various severe autoimmune conditions where an overactive immune response leads to multi-organ failure (https://www.frontiersin.org/articles/10.3389/fimmu.2020.01446/full). Therapeutic strategies addressing this collective group often employ non-specific, high-capacity removal or neutralization methods. These include extracorporeal blood purification techniques, such as therapeutic plasma exchange or specialized adsorbent columns like CytoSorb, which physically remove these substances from the circulation (https://www.mdpi.com/2077-0383/12/11/3759). Additionally, polyvalent agents like intravenous immunoglobulin (IVIG) can neutralize a wide array of these antigens and mediators through diverse mechanisms, including direct binding and Fc-receptor modulation (https://www.ncbi.nlm.nih.gov/books/NBK554446/). Because this term encompasses a heterogeneous group of proteins and molecules with distinct structures and functions, it is not classified as a specific therapeutic target in traditional drug development.

Other names

Circulating inflammatory mediatorsExtracellular pathogenic factorsPlasma-borne antigensHumoral immune mediators

Broad-spectrum removal, neutralization, or dilution of circulating pathogenic substances, including cytokines, chemokines, autoantibodies, and bacterial toxins, from the extracellular space or blood to restore immune homeostasis.